Bronchiectasis: Permanent Airway Dilation, Chronic Infection, and Progressive Lung Damage

Core Idea

Bronchiectasis is permanent enlargement of conducting airways from chronic inflammation and loss of elastic recoil, usually following severe infection or genetic predisposition (CF, immunodeficiency). Impaired mucociliary clearance traps bacteria, establishing a cycle of infection, inflammation, and progressive airway damage.

Explainer

Your foundation in respiratory anatomy established that the conducting airways—from bronchi to bronchioles—are held open by a combination of cartilaginous rings, smooth muscle tone, and elastic connective tissue within the airway walls. Healthy airways are designed to narrow on exhalation and recoil to their resting diameter; this dynamic geometry is essential for both airflow and the mucociliary escalator, the continuous upward sweep of mucus and trapped particles driven by ciliated epithelial cells. Bronchiectasis is what happens when this structural integrity is destroyed.

The initiating event is usually severe or recurrent infection—bacterial pneumonia, tuberculosis, or in genetically predisposed individuals, the thick, dehydrated mucus of cystic fibrosis or the absent antibody response of primary immunodeficiency. From your study of chronic inflammation, you know that prolonged inflammatory signaling causes collateral tissue damage beyond the original insult. In the airway wall, neutrophil-derived proteases (elastase, matrix metalloproteinases) degrade the elastin and collagen that give the bronchus its structural scaffolding. Once the wall is destroyed, it cannot regenerate—the dilation is permanent. The airway wall thickens with fibrotic tissue but loses the elastic recoil that allowed normal dynamic narrowing and recoil.

The architectural damage creates the core pathophysiological problem: impaired mucociliary clearance. Dilated, irregular airways pool secretions rather than transporting them upward. The enlarged diameter reduces airflow velocity, so even intact cilia cannot move mucus efficiently. Bacteria—particularly *Pseudomonas aeruginosa* and *Haemophilus influenzae*—colonize these stagnant secretions and form biofilms, communities of organisms embedded in a polysaccharide matrix that resist both immune clearance and antibiotic penetration. The immune response to persistent bacterial antigen drives further neutrophil recruitment and protease release, which destroys more airway wall, which worsens clearance—a self-perpetuating vicious cycle of infection, inflammation, and structural damage.

The clinical result of this cycle is progressive. Early bronchiectasis may affect only a few segments; over years, the disease can spread to involve multiple lobes. Patients produce copious purulent sputum daily because the impaired clearance mechanism means mucus must be mobilized by coughing rather than ciliary transport. Systemic consequences follow the chronic inflammation model: fatigue, weight loss, and eventually cor pulmonale from progressive hypoxia and pulmonary hypertension. This is the pattern you will revisit in COPD—a different mechanism of airway destruction but the same endpoint of irreversible structural loss and progressive functional decline.